WeVote
Log In

Bill

Bill

SB 1124

Pharmacist Selection and Reimbursement

2025 Regular Session Introduced by Corey Simon

Florida bill allowing patients broader pharmacy selection while adjusting pharmacist reimbursement rates; died in committee without final passage.

Died in Banking and Insurance
#subjectindex
0
WeVote Research Nonpartisan
Bill Summary · SB 1124

Legislative bill overview

SB 1124 would have modified Florida's pharmacy regulations to allow patients greater choice in selecting their pharmacy and would have altered how insurance companies reimburse pharmacists for dispensing medications. The bill sought to address concerns about pharmacy network restrictions and reimbursement rates that some argue limit patient access and pharmacy viability.

Why is this important

Pharmacy selection and reimbursement policies directly affect medication accessibility, healthcare costs, and the financial sustainability of community pharmacies. Changes to these systems can influence drug pricing transparency, patient convenience, and whether independent or smaller pharmacies can remain competitive against large chains.

Potential points of contention

  • Insurance industry opposition: Health insurers typically prefer restrictive pharmacy networks to control costs and negotiate favorable rates; expanded patient choice could increase insurer expenses
  • Reimbursement impact: Altering how pharmacists are reimbursed could either improve pharmacy profitability or create unintended consequences for medication pricing and insurance premiums
  • Scope and implementation details: The bill's specific mechanisms for choice expansion and reimbursement adjustments were likely debated regarding feasibility and fiscal impact

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.